The Board of Directors of Reneo Pharmaceuticals, Inc. has authorized a buyback plan on October 30, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | -2.47% | -12.02% | +0.63% |
13/05 | Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise | MT |
13/05 | OnKure, Inc. entered into an agreement to acquire Reneo Pharmaceuticals, Inc. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.63% | 54.14M | |
+29.70% | 49.18B | |
+0.86% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.64% | 26.09B | |
-22.74% | 18.71B | |
+8.53% | 13.26B | |
+32.24% | 12.32B | |
-1.04% | 11.99B |
- Stock Market
- Equities
- RPHM Stock
- News Reneo Pharmaceuticals, Inc.
- Reneo Pharmaceuticals, Inc. authorizes a Buyback Plan.